General MedicationsINTRAVENOUSStandard
ASCORBIC ACID
ASCORBIC ACID
Standard Dose
25,000MG/50ML (500MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ASCORBIC ACID is listed in Drugs@FDA under application 217131 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ASCORBIC ACID Form and strength SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-08-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview ASCORBIC ACID is listed in Drugs@FDA under application 217131 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ASCORBIC ACID Form and strength SOLUTION;INTRAVENOUS - 25,000MG/50ML (500MG/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2025-08-07 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.